Healthcare provider profile · identity verified

Andreas Cohrssen, MD

Family Practice · NEW YORK, NY · NPI 1316947518

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	280	75
Lisinopril	Lisinopril	192	50
Gabapentin	Gabapentin	187	44
Amlodipine Besylate	Amlodipine Besylate	158	45
Famotidine	Famotidine	145	37
Jardiance	Empagliflozin	140	29
Albuterol Sulfate Hfa	Albuterol Sulfate	122	27
Trulicity	Dulaglutide	119	16
Metformin Hcl	Metformin Hcl	116	30
Fluticasone Propionate	Fluticasone Propionate	109	34
Losartan Potassium	Losartan Potassium	107	25
Amitriptyline Hcl	Amitriptyline Hcl	90	18
Omeprazole	Omeprazole	86	27
Metformin Hcl Er	Metformin Hcl	84	14
Chlorthalidone	Chlorthalidone	76	19
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	75	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	62	14
Diclofenac Sodium	Diclofenac Sodium	61	29
Linzess	Linaclotide	60	11
Metoprolol Succinate	Metoprolol Succinate	60	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	54	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	54	16
Hydrochlorothiazide	Hydrochlorothiazide	52	17
Nifedipine Er	Nifedipine	44	suppressed
Simvastatin	Simvastatin	43	11
Montelukast Sodium	Montelukast Sodium	42	14
Tamsulosin Hcl	Tamsulosin Hcl	42	14
Alendronate Sodium	Alendronate Sodium	41	suppressed
Ammonium Lactate	Ammonium Lactate	39	16
Ozempic	Semaglutide	38	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	37	32
Januvia	Sitagliptin Phosphate	36	12
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	33	suppressed
Meclizine Hcl	Meclizine Hcl	33	11
Clonidine	Clonidine	31	suppressed
Clotrimazole	Clotrimazole	31	12
Eliquis	Apixaban	29	suppressed
Furosemide	Furosemide	29	suppressed
Azelastine Hcl	Azelastine Hcl	28	suppressed
Allopurinol	Allopurinol	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Ibuprofen	Ibuprofen	27	11
Descovy	Emtricitabine/Tenofov Alafenam	26	suppressed
Single Use Swab	Alcohol Antiseptic Pads	26	suppressed
Tresiba Flextouch U-100	Insulin Degludec	26	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	26	suppressed
Sertraline Hcl	Sertraline Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	24	suppressed
Vascepa	Icosapent Ethyl	23	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Trazodone Hcl	Trazodone Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Icosapent Ethyl	Icosapent Ethyl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Naproxen	Naproxen	13	suppressed
Baclofen	Baclofen	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Ciclopirox	Ciclopirox Olamine	12	suppressed
Flunisolide	Flunisolide	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error